Blood test boosts gene detection in lung cancer study

NCT ID NCT04912687

Completed Knowledge-focused Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Mar 06, 2026 · Last updated Apr 28, 2026 · Updated 5 times

Summary

This study looked at whether adding a simple blood test (liquid biopsy) to the standard tissue biopsy helps doctors find more gene changes (EGFR mutations) in people with advanced non-small cell lung cancer. Over 500 patients who had not yet been treated took part. The goal was to see if the combination approach improves detection rates in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHRU Lille

Lille, 59037, France
CHU Nice-Hopital de Cimiel

Nice, 06000, France
CHU Poitiers

Poitiers, 86021, France
CHU Strasbourg

Strasbourg, 67091, France
CHU de Rennes - Hopital Pontchaillou

Rennes, 35033, France
Hospices Civils de Lyon

Lyon, 69002, France
Institut Bergonie

Bordeaux, 33076, France
Institut Curie

Paris, 75248, France
Institut de Cancérologie de l'Ouest - Site Paul Papin

Angers, 49000, France

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR NON SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER